Capital Fund Management (CFM)
HALO icon

Capital Fund Management (CFM)’s Halozyme HALO Stock Holding History

Capital Fund Management (CFM)’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,400
Closed -$504K – 1991
2024
Q1 		$504K Sell
12,400
-6,200
-33% -$232K ﹤0.01% 1861
2023
Q4 		$687K Sell
18,600
-23,500
-56% -$885K ﹤0.01% 1928
2023
Q3 		$1.61M Sell
42,100
-10,400
-20% -$426K 0.01% 1460
2023
Q2 		$1.89M Buy
+52,500
New +$1.79M 0.01% 1208

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Fund Management (CFM)'s HALO Position: Q1 2026 in Review

Capital Fund Management (CFM) reduced its Halozyme (HALO) stake by 21% in Q1 2026, selling an estimated $3.19M and leaving 174,378 shares worth $11.3M. The position accounts for 0.05% of the portfolio, ranked #502.

Capital Fund Management (CFM) first reported a position in HALO in Q2 2013 and has held it in 13 quarters since. The position peaked at $15.6M in Q3 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Capital Fund Management (CFM) held 174,378 shares of Halozyme worth $11.3M as of Q1 2026.
  • Capital Fund Management (CFM) sold 45,201 Halozyme shares in Q1 2026, an estimated $3.19M.
  • Halozyme made up 0.05% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #502 holding.
  • Capital Fund Management (CFM) first reported a position in Halozyme in Q2 2013 and has held it in 13 quarters since.
  • Capital Fund Management (CFM)'s Halozyme position peaked at $15.6M in Q3 2025.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.